Skip to main content
. 2017 Sep 22;8:1173. doi: 10.3389/fimmu.2017.01173

Figure 5.

Figure 5

Longitudinal analysis of miR-155 expression in peripheral blood mononuclear cells (PBMCs) of IA patients during peg-IFN-α-2a therapy. (A) miR-155 mRNA levels in PBMCs at baseline in the SVR and NSVR groups. (B) Temporal dynamics of miR-155 mRNA levels in PBMCs of all patients. (C) Comparison of miR-155 mRNA levels among individuals in the SVR group. (D) Comparison of miR-155 mRNA levels among individuals in the NSVR group. IA, immune activation; SVR, off-treatment sustained virological response; NSVR, non-off-treatment sustained virological response.